123 related articles for article (PubMed ID: 31865247)
1. IgA plasma cell neoplasms are characterized by poorer long-term survival and increased genomic complexity compared to IgG neoplasms.
Habermehl GK; Nakashima MO; Cotta CV
Ann Diagn Pathol; 2020 Feb; 44():151449. PubMed ID: 31865247
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
3. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Mangiacavalli S; Cocito F; Pochintesta L; Pascutto C; Ferretti V; Varettoni M; Zappasodi P; Pompa A; Landini B; Cazzola M; Corso A
Eur J Haematol; 2013 Oct; 91(4):356-60. PubMed ID: 23859528
[TBL] [Abstract][Full Text] [Related]
6. Treatment for IgG and IgA paraproteinaemic neuropathy.
Allen D; Lunn MP; Niermeijer J; Nobile-Orazio E
Cochrane Database Syst Rev; 2007 Jan; (1):CD005376. PubMed ID: 17253554
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of serum immunoglobulins in patients with M protein using cellulose acetate membrane isoelectric focusing.
Iijima S; Shiba K; Kurihara Y; Kamei S; Kimura S; Kimura M; Fukumura Y; Kobayashi I
J Clin Lab Anal; 1999; 13(4):145-50. PubMed ID: 10414593
[TBL] [Abstract][Full Text] [Related]
8. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
9. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
10. The clinical features and prognosis of the monoclonal gammopathy undetermined significance: A single center study.
Ma L; Xu S; Wen L; Liu Y; Kang Y; Huang X; Lu J
Blood Cells Mol Dis; 2018 Nov; 73():9-13. PubMed ID: 30195627
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
12. The clinical aspects of biclonal gammopathies. Review of 57 cases.
Kyle RA; Robinson RA; Katzmann JA
Am J Med; 1981 Dec; 71(6):999-1008. PubMed ID: 6797297
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.
Rostaing L; Modesto A; Abbal M; Durand D
Am J Nephrol; 1994; 14(3):187-91. PubMed ID: 7977478
[TBL] [Abstract][Full Text] [Related]
14. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
[TBL] [Abstract][Full Text] [Related]
16. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of 128 cases of multiple myeloma and 31 cases of monoclonal gammapathies of undetermined significance].
Zhu JZ; Kuo TT; Wang HR
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):463-5, 508. PubMed ID: 2598728
[TBL] [Abstract][Full Text] [Related]
18. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance.
Lloveras E; Solé F; Florensa L; Besses C; Espinet B; Gil M; Pérez-Vila ME; Pedro C; Abella E; Sans-Sabrafen J; Woessner S
Cancer Genet Cytogenet; 2002 Jan; 132(1):25-9. PubMed ID: 11801304
[TBL] [Abstract][Full Text] [Related]
20. [Polyneuropathy and monoclonal IgG/IgA gammopathy--differential neurography on the basis of two patient cases].
Abler B; Gdynia HJ; von Arnim CA
Fortschr Neurol Psychiatr; 2009 Feb; 77(2):105-9. PubMed ID: 19221974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]